ANI PHARMACEUTICALS, INC (ANIP) Operating margin 2016–2025
ANI PHARMACEUTICALS, INC (ANIP) operating margin by fiscal year — reported operating income divided by reported revenue.
12.6%FY2025 · since FY2016: 15.6% → 12.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.6% | +12.5 pp |
| FY2024 | 0.1% | -9.6 pp |
| FY2023 | 9.6% | +20.8 pp |
| FY2022 | -11.2% | +7.3 pp |
| FY2021 | -18.4% | -10.7 pp |
| FY2020 | -7.7% | -15.6 pp |
| FY2019 | 7.9% | -9.6 pp |
| FY2018 | 17.5% | +1.5 pp |
| FY2017 | 16.0% | +0.4 pp |
| FY2016 | 15.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice